NKGN (NKGen Biotech Inc) Yalpi foyda marjasi

NKGen Biotech Inc (NKGN) korporativ emblemasi va logotipi

FDA ning qat'iy nazorati va neyroterapiyadagi patent nizolari tebranishlarni keltirib chiqarmoqda, bu esa haqiqiy daromadlilikni baholash uchun sotilgan tovarlar tannarxidan keyingi yalpi marjani muhim qilmoqda. 0.00 qiymati ushbu ko'rsatkichning joriy miqdorini aks ettiradi. NKGen Biotech, Inc. (NKGN) kognitiv funksiyalarni tiklash uchun NK hujayralari orqali Alzheimer kasalligining inqilobiy davolash usullarini joriy qilmoqda. Bunday dori vositalariga bo'lgan ulkan talab mijozlar bazasining barqaror o'sishini ta'minlaydi.

nkgenbiotech.com (NKGN): Yalpi marja 21.02.2024dan 15.03.2025gacha

nkgenbiotech.com (NKGN) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya kursi va ekspertlarning narx prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:NKGen Biotech
NKGen Biotech, Inc. tomonidan chiqariladigan mahsulotlar

Yalpi foyda marjasi mahsulotni yaratishning bevosita xarajatlarini chegirib tashlagandan keyingi foyda ulushini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi. Ushbu ko'rsatkichning barqarorligi investorlarga barqaror aktivlarni bozor sharoitlari o'zgarganda pasayishga moyil bo'lgan xavfli emitentlardan ajratish imkonini beradi. Joriy yalpi foyda marjasini tahlil qilish orqali NKGen Biotech (NKGN) kompaniyasining Altsgeymer hujayralari terapiyasi sohasidagi strategik ittifoqlari ilmiy sinergiya orqali xarajatlarni qanday optimallashtirayotganini baholash mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi rentabellik CHRO (Chromocell Therapeutics Corp.)|Yalpi marja ELYM (eliemtx.com)|intracellulartherapies.com - Yalpi rentabellik|LBPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi MRNS (Marinus Pharma)|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)